Baxion
Screening
Tags
Alerts
Theme
Prime Medicine, Inc.
PRME
·
NASDAQ
·
$2.97
Share Price as of 11/2
·
$536M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/03/26
10-Q
Q3 ended 09/30/25
11/07/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
08/06/26
8-K
Current report
07/08/26
8-K
Current report
06/08/26
8-K
Current report
05/07/26
8-K
Current report
04/16/26
Prospectuses and Registrations
Filter
POS AM
Post-effective amendment
03/03/26
POSASR
Prospectus / registration
03/03/26
S-8
Registration of securities for employees
03/03/26
S-3ASR
Automatic shelf registration
11/07/25
424B5
Prospectus supplement
07/31/25
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
DEF 14A
Definitive proxy
07/14/25
PRE 14A
Preliminary proxy
07/02/25
DEFA14A
Additional proxy materials
05/19/25
Ownership
Filter
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Other
Filter
ARS
Annual report to shareholders
04/23/26
EFFECT
Request for effectiveness
03/04/26
ARS
Annual report to shareholders
04/22/25
EFFECT
Request for effectiveness
12/20/24
CORRESP
Correspondence with the SEC
12/18/24
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
07/08/26
8-K
Current report
06/08/26
10-Q
Q1 ended 03/31/26
05/07/26
Ownership
Filter
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26
Form 4
Insider transaction
06/08/26